Astrazeneca: Pharma giant snaps up rare disease biotech firm Amoylt March 14, 2024 The acquisition, which is meant to "bolster" Astrazenca's rare disease arm Alexion, brings with it a Phase III investigational therapeutic peptide meant for hypoparathyroidism
Spring Budget 2024: Astrazeneca to invest £650m in Cambridge and Liverpool March 6, 2024 AstraZeneca is to invest £650m in the UK, Chancellor Jeremy Hunt has announced in his Spring Budget.
FTSE 100: London creeps into the green, Currys soars as takeover battle looks likely February 19, 2024 On the FTSE 100, Astrazeneca rose to the top of the index after its Tagrisso drug received positive clinical trial results.
Astrazeneca share price rises as Tagrisso drug shows ‘highly impactful’ results in lung cancer trial February 19, 2024 Results from Tagrisso's Phase III trial showed a "statistically significant and highly clinically meaningful improvement" in progression-free survival.
FTSE 100 close: London dragged lower by Astrazeneca, DS Smith soars after takeover rumours February 8, 2024 Shares in Astrazeneca, the biggest company listed in London, dropped 6.3 per cent even after reporting an increase in revenue in 2023.
Astrazeneca shares plummet despite FTSE 100’s biggest firm posting revenue boost February 8, 2024 Astrazeneca said excluding coronavirus, its total sales increased by 15 per cent, as its chief executive predicted "double digit earnings" for the year ahead.
Labour will ‘get under the bonnet’ of Britain’s growth problem, Starmer to say January 31, 2024 Labour will “roll up our sleeves and get under the bonnet” to fix Britain’s stagnating growth problem, Sir Keir Starmer is set to tell bosses and CEOs.
Labour would host annual investment summit if elected, vows Jonathan Reynolds January 29, 2024 Labour would host an annual business summit to showcase Britain as a global investment destination, if elected into power, Jonathan Reynolds has pledged.
Private sector AI forum to launch in January, No10 announce December 20, 2023 A new artificial intelligence (AI) opportunity forum to explore private sector adoption of the technologies will launch in the new year, No10 have confirmed.
Astrazeneca raises earnings forecast despite evaporation of Covid vaccine demand November 9, 2023 For the third consecutive quarter, strong sales of AstraZeneca's blockbuster cancer treatments and healthy demand for its drugs in emerging markets offset the loss of sales of its COVID-19 vaccine and therapy.